Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Hanne Rolighed Christensen, Jacob Bodilsen et al.|Clinical Infectious Diseases|2021Cited by 93
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosineJan Gerstoft, Jens Lundgren, Ole Kirk et al.|AIDS|2003Cited by 80
K65R with and without S68: A New Resistance Profile in Vivo Detected in Most Patients Failing Abacavir, Didanosine and StavudineBirgit Thorup Røge, Jan Gerstoft, Terese L. Katzenstein et al.|Antiviral Therapy|2003Cited by 68
First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort studyJon Gitz Holler, Zitta Barrella Harboe, Robert Eriksson et al.|BMC Infectious Diseases|2021Cited by 49
Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort StudyMichael Dalager‐Pedersen, Jacob Bodilsen, Stig Lønberg Nielsen et al.|Clinical Infectious Diseases|2021Cited by 49